RVMD
Revolution Medicines·NASDAQ
--
--(--)
--
--(--)
4.92 / 10
Netural
Liquidity flow evaluation: 7.82/10 demonstrating robust fund flow characteristics. Optimistic no significant trends patterns are mitigated by pessimistic overall, block, Small, Medium, Large, and Extra-large indicators, pointing to positive flow perspective. Analyst consensus points to overwhelmingly bullish analyst consensus with strong conviction. Distribution analysis: Strong Buy(33.3%), Buy(66.7%) among 6 research opinions, supported by 2.03 historical weighted rating.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
33%
Buy
67%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-02
InstitutionJP Morgan
Times predicted2
Historical Win Rate100.0%
Is money flowing into or out of RVMD?
- RVMD holds a Bearish analyst rating, with 67% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.92/10 (Netural).
